DE69604713T2 - Retinoide - Google Patents

Retinoide

Info

Publication number
DE69604713T2
DE69604713T2 DE69604713T DE69604713T DE69604713T2 DE 69604713 T2 DE69604713 T2 DE 69604713T2 DE 69604713 T DE69604713 T DE 69604713T DE 69604713 T DE69604713 T DE 69604713T DE 69604713 T2 DE69604713 T2 DE 69604713T2
Authority
DE
Germany
Prior art keywords
retinoids
activity
acitvity
rxr
potentiate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69604713T
Other languages
English (en)
Other versions
DE69604713D1 (de
Inventor
Michael Klaus
Allen John Lovey
Peter Mohr
Michael Rosenberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE69604713D1 publication Critical patent/DE69604713D1/de
Publication of DE69604713T2 publication Critical patent/DE69604713T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/14Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/38Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
    • C07C47/45Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings having unsaturation outside the rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/52Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/548Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings having unsaturation outside the six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09Geometrical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Vapour Deposition (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Cosmetics (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
DE69604713T 1995-02-24 1996-02-14 Retinoide Expired - Fee Related DE69604713T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39398095A 1995-02-24 1995-02-24
US46828995A 1995-06-06 1995-06-06

Publications (2)

Publication Number Publication Date
DE69604713D1 DE69604713D1 (de) 1999-11-25
DE69604713T2 true DE69604713T2 (de) 2000-06-21

Family

ID=27014530

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69604713T Expired - Fee Related DE69604713T2 (de) 1995-02-24 1996-02-14 Retinoide

Country Status (24)

Country Link
US (1) US5986131A (de)
EP (1) EP0728742B1 (de)
JP (1) JP2776787B2 (de)
KR (1) KR100414342B1 (de)
CN (1) CN1124260C (de)
AT (1) ATE185799T1 (de)
AU (1) AU703115B2 (de)
CA (1) CA2170227A1 (de)
CZ (1) CZ291352B6 (de)
DE (1) DE69604713T2 (de)
DK (1) DK0728742T3 (de)
ES (1) ES2138765T3 (de)
FI (1) FI960856A (de)
GR (1) GR3032407T3 (de)
HK (1) HK1012330A1 (de)
HU (1) HU219538B (de)
IL (1) IL117170A (de)
MA (1) MA23813A1 (de)
MY (1) MY113430A (de)
NO (1) NO309189B1 (de)
NZ (1) NZ286017A (de)
RU (1) RU2166499C2 (de)
SG (1) SG59945A1 (de)
TW (1) TW343966B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9814957A (pt) * 1997-11-12 2000-10-03 Hoffmann La Roche Tratamento de doenças imune mediadas por célula auxiliar "t" tipo 2 com antagonistas retinóides
US6326397B1 (en) 1998-11-10 2001-12-04 Hoffman-La Roche Inc. Retinoid antagonists and use thereof
JP4543513B2 (ja) * 2000-07-17 2010-09-15 ソニー株式会社 双方向通信システム、表示装置、ベース装置および双方向通信方法
EP1935869A1 (de) 2000-10-02 2008-06-25 F. Hoffmann-La Roche Ag Retinoide zur Behandlung von Emphysem
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
CA2486303C (en) 2002-05-22 2013-04-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
AU2003291097A1 (en) 2002-11-20 2004-06-15 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
EP1621191A1 (de) * 2004-07-29 2006-02-01 Werner Bollag Behandlung von Entzündungserkrankungen mit RXR-Antagonisten
WO2006010504A1 (en) * 2004-07-29 2006-02-02 Werner Bollag Rxr antagonist treatment against multiple sclerosis
US20080255206A1 (en) * 2005-10-25 2008-10-16 Werner Bollag Rxr Agonists and Antagonists, Alone or in Combination with Ppar Ligands, in the Treatment of Metabolic and Cardiovascular Diseases
CN105646311B (zh) * 2016-03-31 2017-09-26 广州巨元生化有限公司 一种制备β‑阿朴‑8’‑胡萝卜醛的方法
EP3301085A1 (de) * 2016-09-29 2018-04-04 Biogem S.Ca.R.L. Retinoidderivate mit antitumorwirkung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3277147A (en) * 1963-06-05 1966-10-04 Olin Mathieson Lower alkyl esters of beta-cyclocitrylidene fluoroacetic acid and beta-ionylidene fluoroacetic acid
US5514672A (en) * 1981-02-17 1996-05-07 Bazzano; Gail S. Use of retinoids and compositions containing same for hair growth
JPH08511027A (ja) * 1993-01-11 1996-11-19 リガンド・ファーマシューティカルズ・インコーポレーテッド レチノイドxレセプターに対して選択的な活性を有する化合物、およびレチノイドxレセプターによって媒体されたプロセスの調節手段
IL116259A (en) * 1994-12-19 2000-07-16 American Cyanamid Co Analogs of 9-cis retinoic acid and their use

Also Published As

Publication number Publication date
NO960751D0 (no) 1996-02-23
MA23813A1 (fr) 1996-10-01
NO960751L (no) 1996-08-26
NO309189B1 (no) 2000-12-27
EP0728742A2 (de) 1996-08-28
CA2170227A1 (en) 1996-08-25
HU219538B (hu) 2001-05-28
CZ291352B6 (cs) 2003-02-12
EP0728742A3 (de) 1996-10-23
GR3032407T3 (en) 2000-05-31
CN1136557A (zh) 1996-11-27
ATE185799T1 (de) 1999-11-15
TW343966B (en) 1998-11-01
CZ53796A3 (en) 1996-11-13
RU2166499C2 (ru) 2001-05-10
MY113430A (en) 2002-02-28
AU4561796A (en) 1996-09-05
FI960856A0 (fi) 1996-02-23
FI960856A (fi) 1996-08-25
JP2776787B2 (ja) 1998-07-16
HUP9600424A2 (en) 1996-12-30
KR100414342B1 (ko) 2004-05-10
JPH08259527A (ja) 1996-10-08
IL117170A (en) 2000-11-21
HUP9600424A3 (en) 1998-04-28
NZ286017A (en) 1997-12-19
HU9600424D0 (en) 1996-04-29
ES2138765T3 (es) 2000-01-16
EP0728742B1 (de) 1999-10-20
IL117170A0 (en) 1996-06-18
DE69604713D1 (de) 1999-11-25
CN1124260C (zh) 2003-10-15
US5986131A (en) 1999-11-16
SG59945A1 (en) 1999-02-22
KR960031422A (ko) 1996-09-17
DK0728742T3 (da) 2000-04-17
AU703115B2 (en) 1999-03-18
HK1012330A1 (en) 1999-07-30

Similar Documents

Publication Publication Date Title
DE69604713D1 (de) Retinoide
NO970580D0 (no) Retinsyre-X-reseptorligander
KR960700215A (ko) 레티노이드 X 수용체에 대한 선택성을 갖는 화합물(Compounds Having Selectivity for Retinoid X Receptors)
NO943943L (no) Forbindelser med selektivitet for retinoid X reseptorer
KR970706824A (ko) 붕산 에스테르 및 붕산 화합물, 이의 합성 방법 및 용도(boronic ester and acid compounds, synthesis and uses)
DK0678087T3 (da) Forbindelser med selektiv aktivitet til retinoid-X-receptorer og metoder til modulering af processer medieret af retinoid-X
DE69607562T2 (de) Umwandlung von Alkanen zu ungesättigten Carboxylsäuren
ES2129671T3 (es) Sintesis de aminoacidos a partir de acidos carboxilicos y lactamas.
DK702288D0 (da) Dihydropyranderivater
DE69618469T2 (de) Oxidation von aldehyden zu carbonsäuren
TH33708A (th) เอสเทอร์และสารผสมต่าง ๆ ทางเภสัชกรรม
JPS52101412A (en) Dc-dc converter
ITBA930004V0 (it) Dispositivo per migliorare notevolmente l'efficacia conservatrice dei frigoriferi
SU1529678A1 (ru) Способ получения n-винил-2-[1-(1-4,5,6,7-тетрагидроиндолил)-этил]-4,5,6,7-тетрагидроиндола
JPS5934385U (ja) ランプ付腕時計

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee